The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021

“…Vaccination is the most effective way to prevent COVID-19 infection. ACIP recommends the Pfizer-BioNTech COVID-19 vaccine for children aged 5-11 years for the prevention of COVID-19 (10). Preliminary safety findings are similar to those described in the clinical trials.…”

Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 — Six Hospitals, United States, July–August 2021

“…On November 2, 2021, CDC recommended COVID-19 vaccinations for children aged 5-11 years (8). As of July 31, 2021, 29% of U.S. persons aged 12-17 years were fully vaccinated against COVID-19.…”

The COVID-19 pandemic in children and young people during 2020-2021: A complex discussion on vaccination

“…On November 2, 2021, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in children aged 5-11 years for the prevention of COVID-19. The Pfizer-BioNTech COVID-19 vaccine showed high efficacy (>90%) against COVID-19 in children aged 5-11 years [ 166 ].…”

“…Other studies are expected to report results in young people over the age of 12 soon, including the Zydus Cadila vaccine and the Covaxin inactivated coronavirus vaccine, both made in India. Thus far, the vaccines seem to be safe in adolescents, while companies have moved on to carrying out clinical trials in children as young as six months old [ 57 , 166 ].…”